SCHEMBL18784305

SCHEMBL18784305

CCCCCC/C=C\CCCCCCCCC(CO)(CO)CCCCCCCC/C=C\CCCCCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.49
FAAH O00519 7/20 0.48
TRPV1 Q8NER1 1/20 0.48
TERT O14746 3/20 0.47
PTPN1 P18031 3/20 0.47
PPARG P37231 3/20 0.47
PPARD Q03181 3/20 0.47
PPARA Q07869 3/20 0.47
CYP1A2 P05177 2/20 0.47
MAPT P10636 2/20 0.47
CYP2C19 P33261 2/20 0.47
BLM P54132 2/20 0.47
HSD17B10 Q99714 2/20 0.47
FABP4 P15090 2/20 0.47
KMT2A Q03164 2/20 0.47
GMNN O75496 1/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
POLB P06746 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18784258 1.00 HRH3 (0.49) HRH3FAAHTRPV1TERTPTPN1
SCHEMBL18784257 1.00 HRH3 (0.49) HRH3FAAHTRPV1TERTPTPN1
SCHEMBL18784307 1.00 HRH3 (0.49) HRH3FAAHTRPV1TERTPTPN1
SCHEMBL18784320 0.94 ALDH1A1 (0.51) PPARGPPARDPPARAHSD17B10FABP4
SCHEMBL18784290 0.94 ALDH1A1 (0.51) PPARGPPARDPPARAHSD17B10FABP4
SCHEMBL18784322 0.94 ALDH1A1 (0.51) PPARGPPARDPPARAHSD17B10FABP4
SCHEMBL18784313 0.94 ALDH1A1 (0.51) PPARGPPARDPPARAHSD17B10FABP4
SCHEMBL18784327 0.94 ALDH1A1 (0.51) PPARGPPARDPPARAHSD17B10FABP4
SCHEMBL18784325 0.94 ALDH1A1 (0.51) PPARGPPARDPPARAHSD17B10FABP4
SCHEMBL18784311 0.94 ALDH1A1 (0.51) PPARGPPARDPPARAHSD17B10FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3162794-B1 ALKYL SUBSTITUTED AZETIDINES AS CATIONIC LIPID KYOWA KIRIN CO LTD (JP) 2020-09-16 EP disclosed
US-20170224619-A1 CATIONIC LIPID KYOWA HAKKO KIRIN CO., LTD. (JP) 2017-08-10 US disclosed
EP-3162794-A1 CATIONIC LIPID Kyowa Hakko Kirin Co., Ltd. (JP) 2017-05-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170224619-A1 CATIONIC LIPID NPC1L1, NPC1, SGMS1 HRH3 278/4885FAAH 994/4885TRPV1 2576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.